Plain-English translation of NCT06974994 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a supplement called Bifidobacterium bifidum combined with human milk oligosaccharides can help protect newborns from unwanted changes to their gut bacteria caused by antibiotics given at birth. Antibiotics can harm the helpful bacteria in a baby's gut, which may increase the risk of obesity and other health problems later on. Researchers want to see if this medication can restore healthy gut bacteria and reduce these risks.
Antibiotics save lives at birth, but they can also destroy the good bacteria in a newborn's gut microbiome. This imbalance may lead to obesity, chronic diseases, and respiratory infections later in childhood. This study aims to find a safe way to help restore that healthy bacterial balance.
You likely qualify if…
You likely don't qualify if…
If you enroll, your newborn will receive either the supplement or a placebo (inactive treatment) for 2 months. You'll bring your baby to the research clinic for check-ups and monitoring at regular intervals for 2 years. During these visits, researchers will track your child's growth, health, infections, and any changes in their gut bacteria—no major procedures or blood draws beyond standard newborn care.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
Finland